CompanyDrug

Abbisko Therapeutics Receives FDA Approval for Phase I Study of FGFR4 Inhibitor ABSK012

CompanyDeals

Fosun Pharmaceutical and Insightec Collaborate on Non-Invasive Brain Treatment Technology

Policy / Regulatory

9th National Volume-Based Procurement Round Results in 70% Price Reduction for 41 Drugs

CompanyDeals

Qingdao’s Raise Care Secures Over RMB 100 Million in Series B Financing Led by CITIC Capital

CompanyDrug

Chengdu Kanghong Pharmaceutical’s KH629 Receives FDA Approval for NASH Clinical Trial

Company

FibroGen Inc. Reports 155% YOY Sales Increase in Q3 2023 Financial Results

CompanyDeals

GSK Acquires Global Rights to Janssen’s Hepatitis B Antiviral JNJ-3989 in $1 Billion Deal

CompanyDrug

Gilead Sciences and Arcus Biosciences Announce Positive Phase II Data for Domvanalimab Combination Therapy

CompanyDrug

Clover Biopharmaceuticals Submits Market Filing for Seasonal Influenza Vaccine in Brazil

CompanyDeals

WuXi XDC Aims for HKEX Listing with IPO of 178.4 Million Shares

CompanyDrug

Boehringer Ingelheim’s Aldosterone Synthase Inhibitor BI 690517 Shows Promise in CKD Phase II Trial

CompanyDeals

Sun Yat-sen Memorial Hospital Partners with Siemens Healthineers on Metaverse Visualization Surgery